Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-16 Sale | 2024-02-20 4:06 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,615 | $15.62 | $40,840 | 177,839 (Direct) | View |
| 2024-02-16 Sale | 2024-02-20 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 3,010 | $15.62 | $47,009 | 149,450 (Direct) | View |
| 2024-02-16 Sale | 2024-02-20 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Chief Development Officer | 2,267 | $15.62 | $35,405 | 106,931 (Direct) | View |
| 2024-02-16 Sale | 2024-02-20 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 2,267 | $15.62 | $35,405 | 94,018 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,435 | $14.47 | $35,234 | 94,079 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Chief Development Officer | 1,624 | $14.47 | $23,499 | 50,573 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 2,435 | $14.47 | $35,234 | 66,085 (Direct) | View |
| 2024-01-16 Sale | 2024-01-18 4:15 pm | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 1,624 | $14.47 | $23,499 | 47,660 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO | 30,664 | $15.37 | $471,217 | 72,763 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 2,792 | $15.37 | $42,905 | 68,520 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,662 | $15.37 | $25,540 | 52,197 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 1,727 | $15.37 | $26,539 | 49,284 (Direct) | View |
| 2023-12-13 Sale | 2023-12-14 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,792 | $15.37 | $42,905 | 96,514 (Direct) | View |
| 2023-11-30 Sale | 2023-12-01 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 17,801 | $12.57 | $223,755 | 45,435 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 4:11 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,360 | $12.02 | $28,362 | 90,628 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,407 | $12.02 | $16,909 | 48,283 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 4:10 pm | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 1,407 | $12.02 | $16,909 | 62,884 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 4:09 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 2,316 | $12.02 | $27,833 | 63,068 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 4:09 pm | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO | 21,573 | $12.02 | $259,256 | 40,927 (Direct) | View |
| 2023-10-02 Sale | 2023-10-04 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,942 | $12.68 | $37,305 | 84,744 (Direct) | View |
| 2023-06-16 Sale | 2023-06-21 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,238 | $14.4 | $17,829 | 43,812 (Direct) | View |
| 2023-06-16 Sale | 2023-06-21 4:05 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 1,655 | $14.4 | $23,835 | 87,686 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-22 Exercise | 2024-04-24 4:30 pm | 2022-04-28 N/A | Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner | 48,136 | $0 | 23,107,844 (Direct) | View |
| 2024-04-22 Exercise | 2024-04-24 4:30 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner | 48,136 | $0.01 | 23,107,844 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:06 pm | N/A 2034-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 86,375 | $0 | 177,839 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:05 pm | N/A 2034-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 86,375 | $0 | 149,450 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:05 pm | N/A 2034-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama SVP, Chief Development Officer | 58,625 | $0 | 106,931 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:05 pm | N/A 2034-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO | 298,100 | $0 | 298,100 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:05 pm | N/A 2034-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Dhanak Dashyant EVP & Chief Scientific Officer | 86,375 | $0 | 227,275 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 4:05 pm | N/A 2034-02-14 | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 48,625 | $0 | 94,018 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 4:30 pm | 2022-04-28 N/A | Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner | 914,001 | $0 | 23,107,844 (Direct) | View |
| 2024-02-07 Exercise | 2024-02-09 4:30 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner | 914,001 | $0.01 | 23,107,844 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 4:15 pm | N/A 2034-01-15 | Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director | 4,727 | $10.58 | 4,727 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 4:15 pm | N/A 2034-01-15 | Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director | 4,727 | $10.58 | 4,727 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 4:15 pm | N/A 2034-01-15 | Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director | 4,727 | $10.58 | 4,727 (Direct) | View |
| 2024-01-16 Option Award | 2024-01-18 4:15 pm | N/A 2034-01-15 | Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director | 4,727 | $10.58 | 4,727 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 4:05 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO | 62,500 | $0 | 72,763 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 4:05 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 8,244 | $0 | 68,520 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 4:05 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 5,576 | $0 | 52,197 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 4:05 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 5,576 | $0 | 49,284 (Direct) | View |
| 2023-12-12 Option Award | 2023-12-14 4:05 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 8,244 | $0 | 96,514 (Direct) | View |
| 2023-10-28 Option Award | 2023-10-31 4:11 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 8,244 | $0 | 90,628 (Direct) | View |
| 2023-10-28 Option Award | 2023-10-31 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 5,576 | $0 | 48,283 (Direct) | View |
| 2023-10-28 Option Award | 2023-10-31 4:10 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 5,576 | $0 | 62,884 (Direct) | View |
| 2023-10-28 Option Award | 2023-10-31 4:09 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick Chief Financial Officer | 8,244 | $0 | 63,068 (Direct) | View |
| 2023-10-28 Option Award | 2023-10-31 4:09 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. President and CEO | 62,500 | $0 | 40,927 (Direct) | View |
| 2023-09-15 Option Award | 2023-09-19 4:05 pm | N/A 2033-09-14 | Deciphera Pharmaceuticals Inc. | DCPH | Dhanak Dashyant EVP & Chief Scientific Officer | 140,900 | $0 | 206,800 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:05 pm | N/A 2033-06-20 | Deciphera Pharmaceuticals Inc. | DCPH | Martin John Richard Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:05 pm | N/A 2033-06-20 | Deciphera Pharmaceuticals Inc. | DCPH | Benz Edward J. JR Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:05 pm | N/A 2033-06-20 | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:05 pm | N/A 2033-06-20 | Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:05 pm | N/A 2033-06-20 | Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:05 pm | N/A 2033-06-20 | Deciphera Pharmaceuticals Inc. | DCPH | Kelley Susan L. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:05 pm | N/A 2033-06-20 | Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 4:05 pm | N/A 2033-06-20 | Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director | 30,000 | $0 | 30,000 (Direct) | View |